Cellular and pathological functions of tau

C Parra Bravo, SA Naguib, L Gan - Nature Reviews Molecular Cell …, 2024 - nature.com
Tau protein is involved in various cellular processes, including having a canonical role in
binding and stabilization of microtubules in neurons. Tauopathies are neurodegenerative …

Autophagy, aging, and age-related neurodegeneration

JE Palmer, N Wilson, SM Son, P Obrocki, L Wrobel… - Neuron, 2025 - cell.com
Autophagy is a conserved mechanism that degrades damaged or superfluous cellular
contents and enables nutrient recycling under starvation conditions. Many …

Tau oligomer–containing synapse elimination by microglia and astrocytes in Alzheimer disease

RN Taddei, R Perbet, AM de Gerando… - JAMA …, 2023 - jamanetwork.com
Importance Factors associated with synapse loss beyond amyloid-β plaques and
neurofibrillary tangles may more closely correlate with the emergence of cognitive deficits in …

P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy

D Zhang, W Zhang, C Ming, X Gao, H Yuan, X Lin… - Neuron, 2024 - cell.com
Neuronal loss is the central issue in Alzheimer's disease (AD), yet no treatment developed
so far can halt AD-associated neurodegeneration. Here, we developed a monoclonal …

Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice

S Gaikwad, N Puangmalai, M Sonawane… - Science Translational …, 2024 - science.org
Pathological tau aggregates cause cognitive decline in neurodegenerative tauopathies,
including Alzheimer's disease (AD). These aggregates are prevalent within intracellular …

Multivalent Tau/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density

Z Shen, D Sun, A Savastano, SJ Varga… - Nature …, 2023 - nature.com
Alzheimer's disease begins with mild memory loss and slowly destroys memory and
thinking. Cognitive impairment in Alzheimer's disease has been associated with the …

p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003

LW Taylor, EM Simzer, C Pimblett… - Acta …, 2024 - Springer
Tau hyperphosphorylation and aggregation is a common feature of many dementia-causing
neurodegenerative diseases. Tau can be phosphorylated at up to 85 different sites, and …

Membraneless organelles in health and disease: exploring the molecular basis, physiological roles and pathological implications

Y Li, Y Liu, XY Yu, Y Xu, X Pan, Y Sun… - … and Targeted Therapy, 2024 - nature.com
Once considered unconventional cellular structures, membraneless organelles (MLOs),
cellular substructures involved in biological processes or pathways under physiological …

[HTML][HTML] The interplay of protein aggregation, genetics, and oxidative stress in Alzheimer's disease: role for natural antioxidants and immunotherapeutics

J Ali, K Choe, JS Park, HY Park, H Kang, TJ Park… - Antioxidants, 2024 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that comprises
amyloid-beta protein (Aβ) as a main component of neuritic plaques. Its deposition is …

Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems

AK Roghani, RI Garcia, A Roghani, A Reddy… - Ageing Research …, 2024 - Elsevier
The administration of promising medications for the treatment of neurodegenerative
disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's …